<p>This is a summary of the European public assessment report (EPAR) for Evra. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Evra.</p><p>For practical information about using Evra, patients should read the package leaflet or contact their doctor or pharmacist.</p>
Therapeutic Indication
<div class="subsection mt-3-5"> <h3>Therapeutic indication</h3><p>Female contraception.</p> <p>Evra is intended for women of fertile age. The safety and efficacy has been established in women aged 18 to 45 years.</p></div>
Therapeutic Area (MeSH)
ATC Code
G03AA13
ATC Item
N/A
Pharmacotherapeutic Group
Sex hormones and modulators of the genital system
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| norelgestromin | N/A | norelgestromin |
| Ethinyl estradiol | N/A | Ethinyl estradiol |
EMA Name
Evra
Medicine Name
Evra
Aliases
N/ANo risk management plan link.
